Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
about
Circulating glioma biomarkersIdentification of transglutaminase reactive residues in human osteopontin and their role in polymerizationThrombin cleavage of osteopontin disrupts a pro-chemotactic sequence for dendritic cells, which is compensated by the release of its pro-chemotactic C-terminal fragmentOsteopontin expression in the brain triggers localized inflammation and cell death when immune cells are activated by pertussis toxin.Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.Identification of therapeutic targets for glioblastoma by network analysis.Thrombin Cleavage of Osteopontin Modulates Its Activities in Human Cells In Vitro and Mouse Experimental Autoimmune Encephalomyelitis In Vivo.The embryonic type of SPP1 transcriptional regulation is re-activated in glioblastoma.Role of osteopontin in the pathophysiology of cancer.Osteopontin as a therapeutic target for cancer.Liquid biopsies in patients with diffuse glioma.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Immune microenvironment of gliomas.Tumour-processed osteopontin and lactadherin drive the protumorigenic reprogramming of microglia and glioma progression.Thrombin Activity and Thrombin Receptor in Rat Glioblastoma Model: Possible Markers and Targets for Intervention?Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.High-purity recombinant osteopontin N-terminal domain.Osteopontin has a crucial role in osteoclast-like multinucleated giant cell formation.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.
P2860
Q26830329-30D7DA49-03CB-4F73-BD80-F25555873BDCQ28651507-2BEAAB13-B2B0-49F7-A0C3-5376EA93EECCQ34245106-BC70286F-406F-43E4-94FC-01DBFDD95856Q34694713-073C3254-F67A-4987-8513-010E4FEDDDECQ35993007-A4A47852-4191-4F30-ADA3-051E5119BEF2Q36271573-1DBA644C-D159-469A-A36E-1B1AA0EE4EA6Q37127970-E17C59EF-AE13-497B-85F0-686C0F2ACB54Q37725428-7EEDCA25-47C2-46E8-8B20-DD5EED65E746Q38198463-881D1F22-06AB-483D-A850-C8E916A94FF4Q38217758-8FA24265-85CA-4C53-B5B4-6D6CFCF08988Q38365590-DFBC600B-5C10-4B9E-BA2D-ED258E4D9F2BQ38637324-CF1640D6-9CF3-45E5-B0FE-36DD8DE67740Q38712457-61159703-7167-4B37-8D19-D3766023D717Q38780981-7AA3BFAC-5F17-4D62-AE4E-9CE6E7175530Q38908560-11716C5C-CBD5-455A-91FB-40061E8E835EQ40704991-2D984B8C-F9F5-4E73-ABAF-791EB06C514BQ40707819-79AB94F4-0910-477B-89DB-DF4612DC139CQ45796791-60987EDF-9FF0-49CA-BCA1-9156601B0161Q55340253-0ADE5E20-021A-4E95-8D21-41C341C1A1A3
P2860
Thrombin-cleaved fragments of osteopontin are overexpressed in malignant glial tumors and provide a molecular niche with survival advantage.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Thrombin-cleaved fragments of ...... niche with survival advantage.
@ast
Thrombin-cleaved fragments of ...... niche with survival advantage.
@en
type
label
Thrombin-cleaved fragments of ...... niche with survival advantage.
@ast
Thrombin-cleaved fragments of ...... niche with survival advantage.
@en
prefLabel
Thrombin-cleaved fragments of ...... niche with survival advantage.
@ast
Thrombin-cleaved fragments of ...... niche with survival advantage.
@en
P2093
P2860
P356
P1476
Thrombin-cleaved fragments of ...... niche with survival advantage.
@en
P2093
Griffith Harsh
John Morser
Lawrence L K Leung
Lawrence Recht
Michael Glantz
Milton Merchant
Shadi Sharif
Timothy Myles
Xiao-Yan Du
Yasuto Yamaguchi
P2860
P304
P356
10.1074/JBC.M112.362954
P407
P577
2012-11-30T00:00:00Z